Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACLARA BIOSCIENCES INC | 375,000 | reported | 06 Feb 2004 | tx 1+75,000 |
| Adamas Pharmaceuticals Inc | 48,019 | reported | 20 Sept 2019 | tx 9+264,875−4,106 |
| Monogram Biosciences, Inc. | 35,000 | reported | 16 Jan 2009 | tx 5+395,000 |
| Celera CORP | 0 | reported | 17 May 2011 | tx 5+75,000−75,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Sept 2019 | SALE | Adamas Pharmaceuticals Inc | 1,584 | 6.91 USD | |
| 08 Apr 2019 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 25,000 | 0.00 USD | |
| 08 Apr 2019 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 50,000 | 0.00 USD | deriv |
| 20 Mar 2019 | SALE | Adamas Pharmaceuticals Inc | 857 | 7.99 USD | |
| 21 Sept 2018 | SALE | Adamas Pharmaceuticals Inc | 1,665 | 19.18 USD | |
| 06 Mar 2018 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 8,375 | 0.00 USD | |
| 06 Mar 2018 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 50,250 | 0.00 USD | deriv |
| 10 Jul 2017 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 18,750 | 0.00 USD | |
| 10 Jul 2017 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 112,500 | 0.00 USD | deriv |
| 17 May 2011 | OTHER | Celera CORP | 50,000 | 1.66 USD | deriv |
| 10 May 2011 | TENDER | Celera CORP | 15,828 | 8.00 USD | |
| 03 May 2011 | TAX_WITHHOLDING | Celera CORP | 9,172 | 8.00 USD | |
| 03 Jan 2011 | GRANT_AWARD | Celera CORP | 25,000 | 0.00 USD | |
| 03 Jan 2011 | GRANT_AWARD | Celera CORP | 50,000 | 0.00 USD | deriv |
| 16 Jan 2009 | GRANT_AWARD | Monogram Biosciences, Inc. | 35,000 | 0.00 USD | deriv |
| 13 Mar 2008 | GRANT_AWARD | Monogram Biosciences, Inc. | 125,000 | 0.00 USD | deriv |
| 29 Mar 2007 | GRANT_AWARD | Monogram Biosciences, Inc. | 100,000 | 0.00 USD | deriv |
| 07 Apr 2006 | GRANT_AWARD | Monogram Biosciences, Inc. | 100,000 | 0.00 USD | deriv |
| 06 Feb 2004 | GRANT_AWARD | ACLARA BIOSCIENCES INC | 75,000 | 3.20 USD | deriv |